Expression profile of Notch-related genes in multidrug resistant K562/A02 cells compared with parental K562 cells

International Journal of Laboratory Hematology

Volumn 32, Issue 2, 2010, Pages 150-158

  Yan, S ^a   Ma, D ^a   Ji, M ^a   Guo, D ^a   Dai, J ^a   Zhao, P ^a   Ji, C ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Expression; K562; K562 A02; Microarray; Notch

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CD44V ANTIGEN; COLLAGEN; COMPLEMENTARY DNA; DOXORUBICIN; GAMMA INTERFERON; INTERLEUKIN 17; NOTCH RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BASIC REPRODUCTION NUMBER; CANCER RESISTANCE; CELL PROLIFERATION; CELL STRAIN K 562; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DNA MICROARRAY; DRUG ACCUMULATION; FLUORESCENCE; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VALIDATION STUDY; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENES, MDR; HUMANS; INHIBITORY CONCENTRATION 50; K562 CELLS; LEUKEMIA; MICROARRAY ANALYSIS; RECEPTOR, NOTCH1; RECEPTORS, NOTCH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77953594355     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01149.x     Document Type: Article

References (22)

1. Allouche M., Charrad R.S., Bettaieb A., Greenland C., Grignon C. & Smadja-Joffe F. (2000) Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells. Blood 96, 1187-1190.
2. Bai L.Y., Chiu C.F., Lin C.W., Hsu N.Y., Lin C.L., Lo W.J. & Kao M.C. (2008) Differential expression of Sonic hedgehog and Gli1 in hematological malignancies. Leukemia 22, 226-228.
3. Bray S.J. (2006) Notch signalling: a simple pathway becomes complex. Nature Reviews. Molecular Cell Biology 7, 678-689.
4. Fulda S., Kufer M.U., Meyer E., Van Valen F., Dockhorn-Dworniczak B. & Debatin K.M. (2001) Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20, 5865-5877.
5. Jang J., Choi Y.I., Choi J., Lee K.Y., Chung H., Jeon S.H. & Seong R.H. (2006) Notch1 confers thymocytes a resistance to GC-induced apoptosis through Deltex1 by blocking the recruitment of p300 to the SRG3 promoter. Cell Death and Differentiation 13, 1495-1505.
6. Jehn B.M., Bielke W., Pear W.S. & Osborne B.A. (1999) Cutting edge: protective effects of notch-1 on TCR-induced apoptosis. Journal of Immunology 162, 635-638.
7. Kontny H.U., Hammerle K., Klein R., Shayan P., Mackall C.L. & Niemeyer C.M. (2001) Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis. Cell Death and Differentiation 8, 506-514.
8. Leith C.P., Kopecky K.J., Chen I.M., Eijdems L., Slovak M.L., McConnell T.S.,Head D.R., Weick J., Grever M.R., Appelbaum F.R. & Willman C.L. (1999) Significance of the expression of the multi-drug resistance proteins MDR1/Pglycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood 94, 1086-1099.
9. Merchant M.S., Yang X., Melchionda F., Romero M., Klein R., Thiele C.J., Tsokos M., Kontny H.U. & Mackall C.L. (2004) Interferon gamma enhances the effectiveness of tumor necrosis factorrelated apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma. Cancer Research 64, 8349-8356.
10. Miletti-Gonzá lez K.E., Chen S., Muthukumaran N., Saglimbeni G.N., Wu X., Yang J., Apolito K., Shih W.J., Hait W.N. & Rodríguez- Rodríguez L. (2005) The CD44 receptor interacts with p-glycoprotein to promote cell migration and invasion in cancer. Cancer Research 65, 6660-6667.
11. Mungamuri S.K., Yang X., Thor A.D. & Somasundaram K. (2006) Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Research 66, 4715-4724.
12. Nefedova Y., Cheng P., Alsina M., Dalton W.S. & Gabrilovich D.I. (2004) Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood 103, 3503-3510.
13. Nickoloff B.J., Hendrix M.J., Pollock P.M., Trent J.M., Miele L. & Qin J.Z. (2005) Notch and NOXA-related pathways in melanoma cells. The Journal of Investigative Dermatology 10, 95-104.
14. Pece S., Serresi M., Santolini E., Capra M., Hulleman E., Galimberti V., Zurrida S., Maisonneuve P., Viale G. & Di Fiore P.P. (2004) Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. Journal of Cell Biology 167, 215-221.
15. Reya T., O'Riordan M., Okamura R., Devaney E., Willert K., Nusse R. & Grosschedl R. (2000) Wnt signaling regulates b lymphocyte proliferation through a LEF-1-dependent mechanism. Immunity 13, 15-24.
16. Sade H., Krishna S. & Sarin A. (2004) The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells. The Journal of Biological Chemistry 279, 2937-2944.
17. Staal F.J. & Clevers H.C. (2005) WNT signalling and haematopoiesis: a WNTWNT situation. Nature Reviews. Immunology 5, 21-30.
18. Stylianou S., Clarke R.B. & Brennan K. (2006) Aberrant activation of notch signaling in human breast cancer. Cancer Research 66, 1517-1525.
19. Tsuruo T., Naito M., Tomida A., Fujita N., Mashima T., Sakamoto H. & Haga N. (2003) Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Science 94, 15-21.
20. Vincent T., Jourdan M., Sy M.S., Klein B. & Mechti N. (2001) Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein. The Journal of Biological Chemistry 276, 14728-14736.
21. Vincent T., Molina L., Espert L. & Mechti N. (2003) Hyaluronan, a major nonprotein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma. British Journal of Haematology 121, 259-269.
22. Wong W.T., Schumacher C., Salcini A.E., Romano A., Castagnino P., Pelicci P.G. & Di Fiore P.P. (1995) A protein-binding domain, EH, identified in the receptor tyrosine kinase substrate Eps15 and conserved in evolution. Proceedings of the National Academy of Sciences of the United States of America 92, 9530-9534.